TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
Mayer, E.L., Abramson, V., Jankowitz, R., Falkson, C., Marcom, P.K., Traina, T., Carey, L., Rimawi, M., Specht, J., Miller, K., Stearns, V., Tung, N., Perou, C., Richardson, A.L., Componeschi, K., Trippa, L., Tan-Wasielewski, Z., Timms, K., Krop, I., Wolff, A.C., Winer, E.P.
Published in Annals of oncology (01.11.2020)
Published in Annals of oncology (01.11.2020)
Get full text
Journal Article
Genomic profiling of ER + breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance
Giltnane, Jennifer M, Hutchinson, Katherine E, Stricker, Thomas P, Formisano, Luigi, Young, Christian D, Estrada, Monica V, Nixon, Mellissa J, Du, Liping, Sanchez, Violeta, Ericsson, Paula Gonzalez, Kuba, Maria G, Sanders, Melinda E, Mu, Xinmeng J, Van Allen, Eliezer M, Wagle, Nikhil, Mayer, Ingrid A, Abramson, Vandana, Gόmez, Henry, Rizzo, Monica, Toy, Weiyi, Chandarlapaty, Sarat, Mayer, Erica L, Christiansen, Jason, Murphy, Danielle, Fitzgerald, Kerry, Wang, Kai, Ross, Jeffrey S, Miller, Vincent A, Stephens, Phillip J, Yelensky, Roman, Garraway, Levi, Shyr, Yu, Meszoely, Ingrid, Balko, Justin M, Arteaga, Carlos L
Published in Science translational medicine (09.08.2017)
Published in Science translational medicine (09.08.2017)
Get more information
Journal Article
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
Parsons, H.A., Blewett, T., Chu, X., Sridhar, S., Santos, K., Xiong, K., Abramson, V.G., Patel, A., Cheng, J., Brufsky, A., Rhoades, J., Force, J., Liu, R., Traina, T.A., Carey, L.A., Rimawi, M.F., Miller, K.D., Stearns, V., Specht, J., Falkson, C., Burstein, H.J., Wolff, A.C., Winer, E.P., Tayob, N., Krop, I.E., Makrigiorgos, G.M., Golub, T.R., Mayer, E.L., Adalsteinsson, V.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA12 PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2- early breast cancer
Mayer, E.L., Gnant, M.I., DeMichele, A., Martin, M., Burstein, H., Prat, A., Rubovszky, G., Miller, K.D., Pfeiler, G., Winer, E.P., Zdenkowski, N., Anderson, D., Nowecki, Z., Loibl, S., Fohler, H., Metzger, O., Fumagalli, D., Puyana Theall, K., Fesl, C., Dueck, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
Mayer, E.L., DeMichele, A., Rugo, H.S., Miller, K., Waks, A.G., Come, S.E., Mulvey, T., Jeselsohn, R., Overmoyer, B., Guo, H., Barry, W.T., Huang Bartlett, C., Koehler, M., Winer, E.P., Burstein, H.J.
Published in Annals of oncology (01.09.2019)
Published in Annals of oncology (01.09.2019)
Get full text
Journal Article
TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker
Mayer, E.L., Abramson, V., Jankowitz, R., Falkson, C., Marcom, P.K., Traina, T., Carey, L., Rimawi, M., Specht, J., Miller, K., Stearns, V., Tung, N., Perou, C., Richardson, A.L., Componeschi, K., Trippa, L., Tan-Wasielewski, Z., Timms, K., Krop, I., Wolff, A.C., Winer, E.P.
Published in Annals of oncology (13.08.2020)
Published in Annals of oncology (13.08.2020)
Get full text
Journal Article
PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer
Mayer, E.L., Demichele, A.M., Pfeiler, G., Barry, W., Metzger, O., Rastogi, P., Symmans, F., Burstein, H.J., Miller, K., Loibl, S., Schmatloch, S., Goulioti, T., Zardavas, D., Fesl, C., Koehler, M., Huang Bartlett, C., Huang, X., Piccart, M., Winer, E., Gnant, M.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer
Grinshpun, A., Ren, S., Graham, N., DeMeo, M.K., Wrabel, E., Carter, J., Tayob, N., Pereslete, A., Hamilton, E., Juric, D., Mayer, E.L., Tolaney, S.M., Krop, I.E., Metzger, O.
Published in ESMO open (01.06.2024)
Published in ESMO open (01.06.2024)
Get full text
Journal Article
SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer
Mayer, E.L., Dhakil, S., Patel, T., Sundaram, S., Fabian, C., Kozloff, M., Qamar, R., Volterra, F., Parmar, H., Samant, M., Burstein, H.J.
Published in Annals of oncology (01.12.2010)
Published in Annals of oncology (01.12.2010)
Get full text
Journal Article
A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
Lin, N. U., Seah, D. S., Gelman, R., Desantis, S., Mayer, E. L., Isakoff, S., DiPiro, P., Krop, I. E., Come, S. E., Weckstein, D., Winer, E. P., Burstein, H. J.
Published in Breast cancer research and treatment (01.06.2013)
Published in Breast cancer research and treatment (01.06.2013)
Get full text
Journal Article
A new continuing quality improvement tool for evaluating transesophageal echocardiography
Scalia, G.M., Schwarz, K.O., Leung, D.Y., Mayer, E.L., Williams, M.J., Tischler, M.C., Stewart, W.J.
Published in Heart, lung & circulation (01.12.2000)
Published in Heart, lung & circulation (01.12.2000)
Get full text
Journal Article